-+ 0.00%
-+ 0.00%
-+ 0.00%
Inspire Medical Systems appoints AtriCure CEO Michael Carrel to board
Share
Listen to the news
Inspire Medical Systems appoints AtriCure CEO Michael Carrel to board
  • Inspire Medical Systems appointed Michael H. Carrel to its board, effective July 20.
  • Carrel has been president, CEO, and a director of AtriCure since November 2012.
  • He previously served as chairman of Axonics from 2019 to 2024, ending with its sale to Boston Scientific.
  • AtriCure revenue rose to USD 535 million in 2025 from USD 82 million in 2013 during his tenure.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspire Medical Systems Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607270800PRIMZONEFULLFEED9767894) on July 27, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending